和邦生物: 和邦生物关于可转换公司债券2025年跟踪评级结果的公告

Core Viewpoint - The company maintains its credit rating of "AA" with a stable outlook for both its main entity and the convertible bond "HeBang Convertible Bond" [1][2] Group 1: Credit Rating Information - Previous credit rating results indicated a main entity credit rating of "AA" and a stable outlook [1] - The current tracking rating results also show a main entity credit rating of "AA" and a stable outlook [1] - The credit rating for "HeBang Convertible Bond" remains at "AA" [1] Group 2: Rating Agency and Report - The credit rating was conducted by Zhongzheng Pengyuan Credit Rating Co., Ltd. [1] - The rating agency performed a comprehensive analysis of the company's operational environment, competitive situation, and financial aspects [1] - The detailed rating report is available on the Shanghai Stock Exchange website [2]